SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001019056-17-000311
Filing Date
2017-03-22
Accepted
2017-03-22 16:35:07
Documents
2
Group Members
GJG CAPITAL, LLCGJG LIFE SCIENCES, LLCJENNIFER LORENZO

Document Format Files

Seq Description Document Type Size
1 SC 13D matinas_13d.htm SC 13D 98488
2 EXHIBIT 1 ex_1.htm EX-1 9038
  Complete submission text file 0001019056-17-000311.txt   108922
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Subject) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89724 | Film No.: 17707037
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GJG CAPITAL, LLC 107 CIRCLE ROAD STATEN ISLAND NY 10304
Business Address
Lorenzo Jennifer (Filed by) CIK: 0001697285 (see all company filings)

Type: SC 13D